Browsing: Lung

Top Line: Does adjuvant selpercatinib improve outcomes for early stage, RET fusion positive NSCLC?The Study: RET (REarranged during Transfection) encodes…

A thought-provoking dosimetric analysis of 50 lung SBRT plans indicates optimizing median dose to the 4D-tumor (ITV) best translates to…

Top Line: Is dual immune checkpoint inhibition better than durvalumab after chemoradiation for stage III NSCLC?The Study: Chemoradiation followed by…

Top Line: It’s hard to imagine much improving the safety and local control of ablative lung radiation for early-stage lung…

Here’s a multidisciplinary international expert consensus on thoracic reirradiation. In it you’ll find recommendations on careful patient selection with biopsy…

Top Line: Should NSCLC patients who aren’t candidates for concurrent chemoradiation receive immunotherapy and radiation?The Study: The standard treatment for…

Top Line: Does thoracic radiation improve survival in the context of immunotherapy for extensive stage small cell lung cancer?The Study:…

The human microbiome can play an important, thought not fully understood, role in immune modulation and response to immunotherapy. This…

This interesting look at a French cohort of 1480 patients who completed two full years of maintenance immunotherapy for locally-advanced…

In this retrospective series of 265 patients with ≤3 cm, node-negative NSCLC treated with definitive radiotherapy (SBRT or proton therapy),…